• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用 MRI 成像、临床和组织病理学检查结果预测肝门周围胆管癌患者的预后和可切除性。

Prediction of prognosis and resectability using MR imaging, clinical, and histopathological findings in patients with perihilar cholangiocarcinoma.

机构信息

Department of Radiology, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea.

Department of Radiology, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea.

出版信息

Abdom Radiol (NY). 2021 Sep;46(9):4159-4169. doi: 10.1007/s00261-021-03101-z. Epub 2021 Apr 30.

DOI:10.1007/s00261-021-03101-z
PMID:33929600
Abstract

PURPOSE

To predict poor overall survival (OS) and risk of residual tumor after surgery using MR imaging, clinical, and histopathological findings in perihilar cholangiocarcinoma.

METHODS

196 patients with perihilar cholangiocarcinoma who underwent preoperative MRI and curative-intent surgery were retrospectively included. MRI findings were assessed by two radiologists. Clinical characteristics and histopathological results such as serum carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA 19-9), T and N stage, and resection status, were also investigated. Cox regression analysis and the Kaplan-Meier method were used to identify prognostic factors for OS. We further analyzed the correlation between MRI features and residual tumors using logistic regression analysis.

RESULTS

The median OS was 25.0 ± 26.6 months. T stage (hazard ratio [HR] 6.26, p = 0.014), N stage (HR 1.86, p = 0.002), CA-19-9 >37 U/mL (HR 2.06, p < 0.001), enlarged LN on MRI (HR 1.69, p = 0.006), and residual tumor (HR 1.52, p = 0.034) were important predictors of poor survival. The 5-year OS of the complete resection group (n = 107) was significantly better than that of the residual tumor group (n = 89) (35.5% vs. 18.8%, p = 0.002). Additionally, peritumoral fat stranding (odds ratio[OR] 2.09, p = 0.027), Bismuth type III/IV (OR 1.95, p = 0.022), and common bile duct (CBD) involvement (OR 2.3, p = 0.008) on MRI were important predictors of residual tumors in univariate analyses. However, absence of peritumoral fat stranding was a significant independent predictor for complete resection (OR 1.99, p = 0.048) and showed the highest sensitivity, at 79.8%.

CONCLUSION

MR imaging, clinical and histopathological results are useful for predicting poor survival after surgery for perihilar cholangiocarcinoma. Furthermore, MRI findings, including peritumoral fat stranding, CBD involvement, and Bismuth type, are important for the prediction of residual tumors.

摘要

目的

利用磁共振成像(MRI)、临床和组织病理学检查结果,预测肝门部胆管癌患者的总生存期(OS)和术后残留肿瘤的风险。

方法

回顾性纳入 196 例接受术前 MRI 和根治性手术的肝门部胆管癌患者。由两位放射科医生评估 MRI 结果。还调查了临床特征和组织病理学结果,如血清癌胚抗原(CEA)、碳水化合物抗原 19-9(CA 19-9)、T 期和 N 期、以及切除状态。采用 Cox 回归分析和 Kaplan-Meier 法确定 OS 的预后因素。我们还使用逻辑回归分析进一步分析了 MRI 特征与残留肿瘤之间的相关性。

结果

中位 OS 为 25.0±26.6 个月。T 期(风险比 [HR] 6.26,p=0.014)、N 期(HR 1.86,p=0.002)、CA-19-9>37 U/mL(HR 2.06,p<0.001)、MRI 上增大的淋巴结(HR 1.69,p=0.006)和残留肿瘤(HR 1.52,p=0.034)是生存不良的重要预测因素。完全切除组(n=107)的 5 年 OS 明显优于残留肿瘤组(n=89)(35.5%比 18.8%,p=0.002)。此外,MRI 上的肿瘤周围脂肪条纹(比值比[OR] 2.09,p=0.027)、Bismuth Ⅲ/Ⅳ 型(OR 1.95,p=0.022)和胆总管(CBD)受累(OR 2.3,p=0.008)在单因素分析中是残留肿瘤的重要预测因素。然而,肿瘤周围无脂肪条纹是完全切除的显著独立预测因素(OR 1.99,p=0.048),其敏感性最高,为 79.8%。

结论

MR 成像、临床和组织病理学结果可用于预测肝门部胆管癌患者手术后的生存情况。此外,包括肿瘤周围脂肪条纹、CBD 受累和 Bismuth 型在内的 MRI 表现对于残留肿瘤的预测很重要。

相似文献

1
Prediction of prognosis and resectability using MR imaging, clinical, and histopathological findings in patients with perihilar cholangiocarcinoma.使用 MRI 成像、临床和组织病理学检查结果预测肝门周围胆管癌患者的预后和可切除性。
Abdom Radiol (NY). 2021 Sep;46(9):4159-4169. doi: 10.1007/s00261-021-03101-z. Epub 2021 Apr 30.
2
Differences in Prognostic Factors and Recurrence Patterns After Curative-Intent Resection of Perihilar and Distal Cholangiocarcinomas.肝门部胆管癌和远端胆管癌根治性切除术后预后因素及复发模式的差异
Scand J Surg. 2020 Sep;109(3):219-227. doi: 10.1177/1457496919832150. Epub 2019 Feb 21.
3
Lymphocyte to Monocyte Ratio Predicts Resectability and Early Recurrence of Bismuth-Corlette Type IV Hilar Cholangiocarcinoma.淋巴细胞与单核细胞比值预测可切除性和毕氏Ⅳ型肝门胆管癌早期复发。
J Gastrointest Surg. 2020 Feb;24(2):330-340. doi: 10.1007/s11605-018-04086-9. Epub 2019 Jan 22.
4
Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?肝门部胆管癌累及肝门部与肝门部胆管癌根治性切除术后的长期预后和预后因素:是否应将其视为肝门周围胆管癌或加以区分?
Eur J Surg Oncol. 2019 Nov;45(11):2173-2179. doi: 10.1016/j.ejso.2019.06.014. Epub 2019 Jun 11.
5
Elevated preoperative CA125 levels predicts poor prognosis of hilar cholangiocarcinoma receiving radical surgery.术前CA125水平升高预示着接受根治性手术的肝门部胆管癌预后不良。
Clin Res Hepatol Gastroenterol. 2021 Nov;45(6):101695. doi: 10.1016/j.clinre.2021.101695. Epub 2021 Jun 17.
6
Survival analysis of patients with stage T2a and T2b perihilar cholangiocarcinoma treated with radical resection.T2a 和 T2b 肝门周围胆管癌根治性切除术后患者的生存分析。
BMC Cancer. 2020 Sep 3;20(1):849. doi: 10.1186/s12885-020-07357-4.
7
Combined hepatocellular carcinoma-cholangiocarcinoma: MRI features correlated with tumor biomarkers and prognosis.混合型肝细胞癌-胆管细胞癌:与肿瘤标志物和预后相关的 MRI 特征。
Eur Radiol. 2022 Jan;32(1):78-88. doi: 10.1007/s00330-021-08188-y. Epub 2021 Jul 19.
8
Superiority of clinical American Joint Committee on Cancer T classification for perihilar cholangiocarcinoma.肝门部胆管癌临床美国癌症联合委员会 T 分期的优越性。
J Hepatobiliary Pancreat Sci. 2022 Jul;29(7):768-777. doi: 10.1002/jhbp.1066. Epub 2021 Nov 9.
9
High-grade dysplasia/carcinoma in situ of the bile duct margin in patients with surgically resected node-negative perihilar cholangiocarcinoma is associated with poor survival: a retrospective study.手术切除淋巴结阴性肝门周围胆管癌患者胆管边缘高级别发育不良/原位癌与生存不良相关:一项回顾性研究。
J Hepatobiliary Pancreat Sci. 2017 Aug;24(8):456-465. doi: 10.1002/jhbp.481. Epub 2017 Jul 3.
10
Development and Validation of Noninvasive MRI-Based Signature for Preoperative Prediction of Early Recurrence in Perihilar Cholangiocarcinoma.基于非侵入性磁共振成像的肝门部胆管癌术前早期复发预测特征的开发与验证
J Magn Reson Imaging. 2022 Mar;55(3):787-802. doi: 10.1002/jmri.27846. Epub 2021 Jul 23.

引用本文的文献

1
Systematic Review of Preoperative Prognostic Biomarkers in Perihilar Cholangiocarcinoma.肝门部胆管癌术前预后生物标志物的系统评价
Cancers (Basel). 2024 Feb 7;16(4):698. doi: 10.3390/cancers16040698.
2
Preoperative Osteopenia Is Associated with Significantly Shorter Survival in Patients with Perihilar Cholangiocarcinoma.术前骨质减少与肝门部胆管癌患者的生存期显著缩短相关。
Cancers (Basel). 2022 Apr 28;14(9):2213. doi: 10.3390/cancers14092213.
3
Emerging Therapies for Advanced Cholangiocarcinoma: An Updated Literature Review.

本文引用的文献

1
Imaging of malignancies of the biliary tract- an update.胆道恶性肿瘤的影像学——最新进展
Cancer Imaging. 2014 Apr 22;14(1):14. doi: 10.1186/1470-7330-14-14.
晚期胆管癌的新兴疗法:最新文献综述
J Clin Med. 2021 Oct 24;10(21):4901. doi: 10.3390/jcm10214901.